Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Richard Dutton

General Anesthesiology · UMSOM

View

Dr. Sarah Ro

Obesity Medicine · UNC Health Care

View

Dr. Jed Wolpaw

Critical Care · Johns Hopkins

View

Dr. Matt Sherrer

Perioperative Med · UAB

View

Dr. Reema Dbouk

Obesity Medicine · Emory University

View

Dr. Jennifer Paisley

Obesity Medicine · St. Elizabeth Medical Center

View

Dr. Chris Beyrer

Global Health · Duke University

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Neuroimaging Spectrum of GM1 Gangliosidosis with Description of Novel Imaging Signs.

    Feb 3, 2026DOI: 10.3174/ajnr.a8973Journal ArticleAJNR

    Written by: Fiorenza CoppolaSandeep PrasadGiovanni MoranaMatthew T WhiteheadReem ZakzoukAmirreza ManteghinejadFelipe Welter LangerJuliano Adams PerezFelice D'ArcoUlrike LöbelPritika GaurPatricia VargaJulien BaruteauKshitij MankadSniya SudhakarAsthik Biswas

    Find these authors on Roon

    FD
    Dr. Felice D’Arco
    Peds Epilepsy

    Summary

    BACKGROUND AND PURPOSE: GM1 gangliosidosis is a rare lysosomal storage disorder caused by pathogenic variants in the GLB1 gene, leading to deficient β-galactosidase activity and accumulation of gangliosides. This multi-institutional retrospective study aims to systematically characterize neuroimaging features across all clinical subtypes of GM1 gangliosidosis.MATERIALS AND METHODS: Patients were retrospectively identified from 4 centers based on confirmed GLB1 variants or β-galactosidase deficiency. Imaging acquired post gene therapy or with poor quality was excluded. Clinical subtypes were classified by age of onset. A total of 35 brain MRIs and 3 CTs from 24 patients (aged 0-19 years) were reviewed. Imaging was assessed for white matter patterns, deep gray nuclei signal changes, atrophy, and the presence of occipitomastoid suture hypertrophy.RESULTS: The cohort included patients with infantile- (13), late-infantile- (6), juvenile- (4), and adult-onset (1). White matter abnormalities were present in all but one infantile/late-infantile patient and absent in juvenile/adult-onset subtypes. Patients with infantile-onset predominantly showed hypomyelination with the posterior limb of the internal capsule sparing. Late-infantile subtypes demonstrated a spectrum from mixed to nonhypomyelinating patterns, including periventricular and deep white matter involvement with sparing of subcortical regions. Internal hypertrophy of the occipitomastoid sutures was seen in more than one-half of the infantile and late-infantile-onset subtypes. One patient in the infantile cohort showed linear subcortical and basal ganglia calcifications. Thalamic T2 hypointensity with anterior and lateral nuclear group predilection was a consistent feature across all subtypes, progressing in early-onset groups. Juvenile and adult cases showed dorsal putaminal T2 hyperintensity and globus pallidus T2 hypointensity, with the latter corresponding to mineralization on SWI. Progressive cerebral and cerebellar atrophy was observed in all subtypes with available follow-up imaging.CONCLUSIONS: Distinct imaging patterns are evident across GM1 gangliosidosis subtypes: leukodystrophy dominates in early-onset forms, while juvenile and adult forms are characterized by globus pallidus mineralization and dorsal putaminal atrophy. Thalamic T2 hypointensity is consistent across all subtypes, with predilection for the anterior and lateral nuclear groups. Internal hypertrophy of the occipitomastoid sutures, previously undescribed in GM1 gangliosidosis, is a common feature of early-onset cases.
    FDDr. Felice  D’Arco

    Dr. Felice D’Arco

    Pediatric Neurology · Pediatric Epilepsy
    felice